| Name | Title | Contact Details |
|---|
The Helper Bees is a technology platform focused on enhancing the aging-in-place experience for older adults in the healthcare sector. Founded in 2015 and based in Austin, Texas, the company operates across all 50 U.S. states, Washington D.C., and Puerto Rico. It offers a wide range of non-medical in-home care services, including home care, home modifications, pest control, and meal delivery, all facilitated through its Aging-In-Place Provider Network. The platform features several tools to ensure quality care, such as automatic fulfillment that monitors service quality, digital invoicing and payment systems, and digital claims tools to streamline processes and improve data collection. Additionally, the company provides care concierge services to help individuals navigate their supplemental benefits and manage payments. The Helper Bees partners with major insurance carriers and health plans to improve in-home care delivery and reduce healthcare costs, making aging in place more accessible for seniors and their families.
MHI is a Japan-based multinational engineering company that owns and operates businesses in sectors such as energy, transportation and defense.
Prime Case LLC is a leading provider of lawsuit funding and lawsuit advances for those expecting a cash settlement resulting from a pending lawsuit, verdict or judgment. The need for our legal funding & settlement funding service arises from the fact that the legal process is often slow and many plaintiffs simply cannot afford to wait for a fair settlement due to financial pressures. Prime Case LLC works directly with attorneys and paralegals nationwide to provide their clients with immediate financial help. Our attorney-focused, the plaintiff funding process is the simple, fast, and cost-effective way to fund your clients. Here at Prime Case Funding, we want to save both you and your staff time to focus on getting your client the largest case settlement possible. Referring Your Clients to Prime Case Funding means: 1. Simple Application 2. Minimal Paperwork 3.No Case Interference 4. Consistent Funding Agreements 5. Quick Funding Turnaround 6. Low Funding Rates Prime Case LLC will limit funding to 10%-15% of the case value, to ensure your ability to settle the case will not be compromised. In our experience, plaintiff funding never affects attorney fees or the way your firm handles the case.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.